534 related articles for article (PubMed ID: 11228481)
1. The role of human papillomavirus deoxyribonucleic acid assay and repeated cervical cytologic examination in the detection of cervical intraepithelial neoplasia among human immunodeficiency virus-infected women. Cervical Disease Study Group of the American Foundation for AIDS Research Community Based Clinical Trials Network.
Cohn JA; Gagnon S; Spence MR; Harrison DD; Kluzak TR; Langenberg P; Brinson C; Stein A; Hellinger J;
Am J Obstet Gynecol; 2001 Feb; 184(3):322-30. PubMed ID: 11228481
[TBL] [Abstract][Full Text] [Related]
2. Is human papillomavirus testing an effective triage method for detection of high-grade (grade 2 or 3) cervical intraepithelial neoplasia?
Adam E; Kaufman RH; Berkova Z; Icenogle J; Reeves WC
Am J Obstet Gynecol; 1998 Jun; 178(6):1235-44. PubMed ID: 9662307
[TBL] [Abstract][Full Text] [Related]
3. Papillomavirus detection: demographic and behavioral characteristics influencing the identification of cervical disease.
Adam E; Berkova Z; Daxnerova Z; Icenogle J; Reeves WC; Kaufman RH
Am J Obstet Gynecol; 2000 Feb; 182(2):257-64. PubMed ID: 10694321
[TBL] [Abstract][Full Text] [Related]
4. A population-based study of human papillomavirus deoxyribonucleic acid testing for predicting cervical intraepithelial neoplasia.
Kjellberg L; Wiklund F; Sjöberg I; Wadell G; Angström T; Dillner J; Mählck CG
Am J Obstet Gynecol; 1998 Dec; 179(6 Pt 1):1497-502. PubMed ID: 9855587
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance.
Cox JT; Lorincz AT; Schiffman MH; Sherman ME; Cullen A; Kurman RJ
Am J Obstet Gynecol; 1995 Mar; 172(3):946-54. PubMed ID: 7892889
[TBL] [Abstract][Full Text] [Related]
6. Does typing of human papillomavirus assist in the triage of women with repeated low-grade, cervical cytologic abnormalities?
Fait G; Daniel Y; Kupferminc MJ; Lessing JB; Niv J; Bar-Am A
Gynecol Oncol; 1998 Sep; 70(3):319-22. PubMed ID: 9790781
[TBL] [Abstract][Full Text] [Related]
7. Value of human papillomavirus deoxyribonucleic acid testing after conization in the prediction of residual disease in the subsequent hysterectomy specimen.
Lin CT; Tseng CJ; Lai CH; Hsueh S; Huang KG; Huang HJ; Chao A
Am J Obstet Gynecol; 2001 Apr; 184(5):940-5. PubMed ID: 11303202
[TBL] [Abstract][Full Text] [Related]
8. Detection of cervical intraepithelial neoplasia in women with atypical squamous or glandular cells of undetermined significance cytology: a prospective study.
Wensveen C; Kagie M; Veldhuizen R; De Groot C; Denny L; Zwinderman K; Trimbos B
Acta Obstet Gynecol Scand; 2003 Sep; 82(9):883-9. PubMed ID: 12911453
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus testing as triage for atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesions: sensitivity, specificity, and cost-effectiveness.
Kaufman RH; Adam E; Icenogle J; Reeves WC
Am J Obstet Gynecol; 1997 Oct; 177(4):930-6. PubMed ID: 9369847
[TBL] [Abstract][Full Text] [Related]
10. Relevance of human papillomavirus screening in management of cervical intraepithelial neoplasia.
Kaufman RH; Adam E; Icenogle J; Lawson H; Lee N; Reeves KO; Irwin J; Simon T; Press M; Uhler R; Entman C; Reeves WC
Am J Obstet Gynecol; 1997 Jan; 176(1 Pt 1):87-92. PubMed ID: 9024095
[TBL] [Abstract][Full Text] [Related]
11. The IMproving Primary Screening And Colposcopy Triage trial: human papillomavirus, cervical cytology, and histopathologic results from the baseline and 1-year follow-up phase.
Safaeian M; Wright TC; Stoler MH; Ranger-Moore J; Rehm S; Aslam S; Fang Q; Volkir P; Ridder R
Am J Obstet Gynecol; 2021 Sep; 225(3):278.e1-278.e16. PubMed ID: 33852886
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral.
Kulasingam SL; Hughes JP; Kiviat NB; Mao C; Weiss NS; Kuypers JM; Koutsky LA
JAMA; 2002 Oct; 288(14):1749-57. PubMed ID: 12365959
[TBL] [Abstract][Full Text] [Related]
13. Combined Pap smear, cervicography and HPV DNA testing in the detection of cervical intraepithelial neoplasia and cancer.
Costa S; Sideri M; Syrjänen K; Terzano P; De Nuzzo M; De Simone P; Cristiani P; Finarelli AC; Bovicelli A; Zamparelli A; Bovicelli L
Acta Cytol; 2000; 44(3):310-8. PubMed ID: 10833984
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic performance of Hybrid Capture human papillomavirus deoxyribonucleic acid assay combined with liquid-based cytologic study.
Ferenczy A; Franco E; Arseneau J; Wright TC; Richart RM
Am J Obstet Gynecol; 1996 Sep; 175(3 Pt 1):651-6. PubMed ID: 8828429
[TBL] [Abstract][Full Text] [Related]
15. Contribution of human papillomavirus testing by hybrid capture in the triage of women with repeated abnormal pap smears before colposcopy referral.
Fait G; Kupferminc MJ; Daniel Y; Geva E; Ron IG; Lessing JB; Bar-Am A
Gynecol Oncol; 2000 Nov; 79(2):177-80. PubMed ID: 11063640
[TBL] [Abstract][Full Text] [Related]
16. Adjunctive human papillomavirus testing in the 2-year follow-up of women with low-grade cervical cytologic abnormalities: a randomized trial and economic evaluation.
Lytwyn A; Sellors JW; Mahony JB; Daya D; Chapman W; Howard M; Roth P; Lorincz AT; Gafni A; Walter SD
Arch Pathol Lab Med; 2003 Sep; 127(9):1169-75. PubMed ID: 12946228
[TBL] [Abstract][Full Text] [Related]
17. High-risk cervical epithelial neoplasia grade 1 treated by loop electrosurgical excision: follow-up and value of HPV testing.
Alonso I; Torné A; Puig-Tintoré LM; Esteve R; Quinto L; Garcia S; Campo E; Pahisa J; Ordi J
Am J Obstet Gynecol; 2007 Oct; 197(4):359.e1-6. PubMed ID: 17714678
[TBL] [Abstract][Full Text] [Related]
18. An evaluation of human papillomavirus testing for intermediate- and high-risk types as triage before colposcopy.
Hatch KD; Schneider A; Abdel-Nour MW
Am J Obstet Gynecol; 1995 Apr; 172(4 Pt 1):1150-5; discussion 1155-7. PubMed ID: 7726250
[TBL] [Abstract][Full Text] [Related]
19. Treatment of women with low-grade squamous intraepithelial lesions on cytologic evidence or biopsy results by board-certified gynecologists.
Lee C; Mancuso V; Contant T; Jackson R; Smith-Mccune K
Am J Obstet Gynecol; 2003 Mar; 188(3):693-8. PubMed ID: 12634642
[TBL] [Abstract][Full Text] [Related]
20. Benefit and burden in the Dutch cytology-based vs high-risk human papillomavirus-based cervical cancer screening program.
Loopik DL; Koenjer LM; Siebers AG; Melchers WJG; Bekkers RLM
Am J Obstet Gynecol; 2021 Feb; 224(2):200.e1-200.e9. PubMed ID: 32800820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
